All MasterControl articles
-
WebinarHarnessing AI to transform quality and manufacturing in life sciences
This webinar explores innovative, purpose-built AI solutions that elevate compliance and efficiency in quality and manufacturing operations.
-
WebinarTrends for life sciences quality leaders in 2025 - mastering what matters
This webinar explores the major trends impacting life sciences in 2025 and how the pharma industry can capitalise on the latest developments shaping quality management.
-
WebinarTurning quality management into quality leadership
This webinar discusses the power of a comprehensive QMS to ensure efficiency, compliance, and product quality.
-
WebinarPharmaceutical continuous manufacturing: what’s next for industry?
During this virtual panel, industry experts will discuss adoption of continuous manufacturing in the pharmaceutical industry.
-
Article2024 Pharmaceutical industry trends - discover the latest pharma quality and manufacturing trends
Some of the most sought-after human experiences are health and happiness. Although pharmaceutical companies cannot determine personal happiness, they are working to improve personal health outcomes that can tip the scale. The demand for personalised medicines, cell and gene therapies, hyperresponsive and patient-centric healthcare, real-world data fuelled by artificial intelligence ...
-
Video
Gaining competitive advantage in digital quality management
Watch this webinar to learn about the current state of digitisation in life sciences and where your peers rank on the quality digital maturity spectrum.
-
Webinar
Gaining competitive advantage in digital quality management
Watch this webinar to learn about the current state of digitisation in life sciences and where your peers rank on the quality digital maturity spectrum.
-
NewsQMS market to value nearly $4b by 2030
Research predicts the pharma quality management systems (QMS) market will grow significantly in the next several years and is projected to value $3.97 billion by 2030.
-
NewsCGT supply chain and logistics market worth $3.12b by 2031
Improvements in real-time supply chain operations is expected to drive the cell and gene therapy supply chain/logistics market, a report says.